Login to Your Account

Phytopharm Falls on Cogane Failure, Seeks Strategic Review

By Nuala Moran and Cormac Sheridan
Staff Writers

Tuesday, February 19, 2013
LONDON – One of the UK's oldest biotech companies looks to be on its way out after reporting the failure of the lead program in Parkinson's disease.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription